|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication October 24, 2006.
Revised March 27, 2007.
Accepted for publication March 28, 2007.
Within the family of serotonin receptors, the 5-HT3 receptor is the only ligand-gated ion channel. It is composed of five subunits, of which the 5-HT3A and 5-HT3B subunits are best characterized. Several studies, however, have reported on the functional diversity of native 5-HT3 receptors which cannot solely be explained on the basis of the 5-HT3A and 5-HT3B subunits. Following our discovery of further putative 5-HT3 serotonin receptor encoding genes, HTR3C, HTR3D and HTR3E, we investigated wether these novel candidates and the isoform 5-HT3Ea are able to form functional 5-HT3 receptor complexes. Using immunofluorescence and immunoprecipitation studies of heterologous expressed proteins, we found that each of the respective candidates co-assembles with 5-HT3A. To investigate if the novel subunits modulate 5-HT3 receptor function, we performed radioligand-binding assays and calcium-influx studies in HEK293 cells. Our experiments revealed that the 5-HT3C, D, E and Ea subunit alone cannot form functional receptors. Co-expression with 5-HT3A, however, result in the formation of functional heteromeric complexes with different serotonin efficacies. Potencies of two agonists and antagonists were nearly identical with respect to homomeric 5-HT3A and heteromeric complexes. However, 5-HT showed increased efficacy with respect to 5-HT3A/D and 5-HT3A/E receptors, which is consistent with the increased surface expression compared to 5-HT3A receptors. In contrast, 5-HT3A/C and 5-HT3A/Ea receptors exhibited decreased 5-HT efficacy. This data shows for the first time that the novel 5-HT3 subunits are able to form heteromeric 5-HT3 receptors which exhibit quantitatively different functional properties compared to homomeric 5-HT3A receptors.
Key words:
Serotonin, Serotonin, Func. analysis receptor/ion channel mutants, Immunocytochemistry, Receptor binding studies
This article has been cited by other articles:
![]() |
J. Kapeller, L. A. Houghton, H. Monnikes, J. Walstab, D. Moller, H. Bonisch, B. Burwinkel, F. Autschbach, B. Funke, F. Lasitschka, et al. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome Hum. Mol. Genet., October 1, 2008; 17(19): 2967 - 2977. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Noam, W. J. Wadman, and J. A. van Hooft On the voltage-dependent Ca2+ block of serotonin 5-HT3 receptors: a critical role of intracellular phosphates J. Physiol., August 1, 2008; 586(15): 3629 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Livesey, M. A. Cooper, T. Z. Deeb, J. E. Carland, J. Kozuska, Tim. G. Hales, J. J. Lambert, and J. A. Peters Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor J. Biol. Chem., July 11, 2008; 283(28): 19301 - 19313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krzywkowski, P. A. Davies, P. L. Feinberg-Zadek, H. Brauner-Osborne, and A. A. Jensen High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor PNAS, January 15, 2008; 105(2): 722 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Fink and M. Gothert 5-HT Receptor Regulation of Neurotransmitter Release Pharmacol. Rev., December 1, 2007; 59(4): 360 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Andres, C. de Hemptinne, and J. Bertranpetit Heterogeneous Rate of Protein Evolution in Serotonin Genes Mol. Biol. Evol., December 1, 2007; 24(12): 2707 - 2715. [Abstract] [Full Text] [PDF] |
||||